Research Article
Epilepsy Treatment Outcome and Its Predictors among Ambulatory Patients with Epilepsy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia
Table 3
Antiepileptic drugs and associated adverse effects among epileptic patients on AEDs at MTUTH from March 10 to April 10, 2018.
| Antiepileptic drug | Adverse effects | Frequency (%) |
| Types of AEDs used | Phenobarbitone alone | 90 (62.9) | Phenytoin alone | 23 (16.1) | Phenobarbitone plus phenytoin | 17 (11.9) | Phenobarbitone plus carbamazepine | 9 (6.3) | Carbamazepine plus phenytoin | 4 (2.8) | AEDs prescribed as initial therapy | Phenobarbitone | 117 (81.8) | Phenytoin | 22 (15.4) | Carbamazepine | 4 (2.8) | AEDs prescribed as add-on therapy | Phenytoin | 21 (14.7) | Carbamazepine | 12 (8.4) | Polytherapy with AEDs | Yes | 30 (21.0) | No | 113 (79.0) | Polytherapy irrespective of AEDs | Yes | 70 (48.9) | No | 73 (51.1) | Antiepileptic-related adverse effects | Yes | 104 (72.7) | No | 39 (27.3) | Types of antiepileptic associated adverse effects | Sedation | 78 (54.5%) | Confusion | 10 (7.0) | Weakness | 9 (6.3) | Gingival hyperplasia | 9 (6.3) | Rash | 7 (4.9) | Blurred vision | 6 (4.2) | GI irritation | 4 (2.8) |
|
|